Matsushima, Tomohiro
Eisai (Japan)
2 papers on CoChatORCID 0000-0002-3306-0320
Most cited papers
- Verified
Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage.
Yamamoto, Y., Matsui, J., Matsushima, T., Obaishi, H., Miyazaki, K., Nakamura, K., Tohyama, O., Semba, T., Yamaguchi, A., Hoshi, S., et al. (2014) · Vascular Cell
Angiogenesis and VEGF in CancerLymphatic System and Diseases
Cited by 507
- Verified
Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization.
Okamoto, K., Ikemori-Kawada, M., Jestel, A., von König, K., Funahashi, Y., Matsushima, T., Tsuruoka, A., Inoue, A., & Matsui, J. (2015) · ACS Medicinal Chemistry Letters
Angiogenesis and VEGF in CancerEnzyme Structure and Function
Cited by 285
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free